Trials
MRD trials
The curated index is a sourced list of studies. Accruing is the live ClinicalTrials.gov set of studies that are recruiting or not yet recruiting. DYNAMIC-III is not in the curated index because it is registered in Australia and New Zealand, not with an NCT id.
Recruiting and not-yet-recruiting studies that use ctDNA, cfDNA, or MRD in eligibility, a treatment decision, or a primary or secondary endpoint, plus observational studies focused on that testing. 1123 studies from 2267 registry records. Hematologic trials that list MRD only as a secondary endpoint are listed separately. Last synced Nov 18, 2026, 2:04 PM EST.
Testing the Investigational Medication Pembrolizumab After Kidney Removal for Patients With Non-Clear Cell Renal Cell Carcinoma
National Cancer Institute (NCI) · Locations not reported · Updated 2026-07-08
An Exploratory Study on the Failure of Immunotherapy With Vorolanib Combined With Everolimus
Sun Yat-sen University · 2 locations · Updated 2026-10-22
Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)
Jinling Hospital, China · 1 locations · Updated 2026-11-17
Intensified Monitoring of PhArmacology of Cabozantinib as a Tool for Toxicity Management in Patients With Renal Cell Carcinoma
Centro di Riferimento Oncologico - Aviano · 1 locations · Updated 2026-09-04
Promoting Response to IMmunotherapy by Exercise in Patients With Advanced Renal Cell Carcinoma
Radboud University Medical Center · 2 locations · Updated 2026-08-28
Personalized ctDNA Monitoring for Predicting Immunotherapy Outcomes in Advanced Non-Clear Cell Renal Cell Carcinoma
West China Hospital · Locations not reported · Updated 2026-08-20
The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN Trial
Yonsei University · 3 locations · Updated 2023-06-22
Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA
Yonsei University · 1 locations · Updated 2019-12-13
Status can change after this sync. The curated list is the other view on this page. Evidence holds the published results.